“New National Purpose”: Protas named in Blair-Hague report on innovation
Protas named in report by William Hague and Tony Blair on harnessing innovation in science and tech.
The latest in smarter trials
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
Protas signs strategic partnership with Moderna
Moderna is a leading biotechnology company pioneering mRNA. Its mission is to deliver the greatest possible impact to people.
Protas IT contract awarded to Slalom
Protas awards the contract to develop and operate a unified clinical trials management platform to Slalom.
Protas signs strategic collaboration with Regeneron
Protas and Regeneron, the leading biotechnology company, announce a strategic, long-term collaboration.
Protas announces grant funding from Flu Lab
Protas has announced a £5 million grant from Flu Lab, a charitable organisation fuelling bold approaches to defeat influenza.
Protas appoints Beth Thompson to its board
Protas is pleased to announce the appointment of Dr Beth Thompson MBE to its Board of Directors.
Protas receives grant from venture capital firm GV
The £5m grant recognises the unique ability of Protas to deliver better clinical trials.
Protas receives support from Schmidt Futures
Protas has been awarded a grant by the philanthropic initiative founded by Eric and Wendy Schmidt.
Protas: BBC Radio 4 interviews Prof Sir Martin Landray
Sir Martin featured on The Life Scientific, which explores the life and work of renowned scientists.
Clinical Trials Day: Prof Sir Martin Landray, Chief Executive Officer
Sir Martin shares his experience with clinical trials and what they mean to him.
Procurement: unified clinical trials management platform
Protas has recently released a contract notice for a unified clinical trials management platform (UCTMP).
Protas interviewed by The Lancet for new Research Focus
The medical journal has published an in-depth article exploring Protas’ work and mission.